Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficienceis

Stein, MR; Nelson, RP; Church, JA; Wassermann, RL; Borte, M; Vermylen, C; Pichler, WJ (2009). Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficienceis. Journal of clinical immunology, 29(1), pp. 137-144. New York, N.Y.: Springer 10.1007/s10875-008-9231-2

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Pichler, Werner Joseph

ISSN:

0271-9142

Publisher:

Springer

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:12

Last Modified:

08 Jun 2016 10:52

Publisher DOI:

10.1007/s10875-008-9231-2

Web of Science ID:

000262987100017

URI:

https://boris.unibe.ch/id/eprint/31561 (FactScience: 196166)

Actions (login required)

Edit item Edit item
Provide Feedback